Perspective Therapeutics, Inc. (CATX)
2.16
-0.01
(-0.46%)
USD |
NYAM |
Oct 19, 13:58
Perspective Therapeutics Cash from Operations (Annual) : -82.48M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -82.48M |
| December 31, 2024 | -18.29M |
| December 31, 2023 | -36.91M |
| June 30, 2022 | -7.71M |
| June 30, 2021 | -2.837M |
| June 30, 2020 | -3.641M |
| June 30, 2019 | -5.049M |
| June 30, 2018 | -5.712M |
| June 30, 2017 | -5.712M |
| June 30, 2016 | -3.884M |
| June 30, 2015 | -3.522M |
| June 30, 2014 | -3.228M |
| June 30, 2013 | -3.056M |
| Date | Value |
|---|---|
| June 30, 2012 | -2.448M |
| June 30, 2011 | -2.419M |
| June 30, 2010 | -2.686M |
| June 30, 2009 | -3.949M |
| June 30, 2008 | -7.725M |
| June 30, 2007 | -7.202M |
| June 30, 2006 | -7.003M |
| June 30, 2005 | -3.386M |
| June 30, 2004 | -0.6263M |
| September 30, 2003 | |
| September 30, 2002 | -0.0089M |
| September 30, 2001 | -0.0147M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Anika Therapeutics, Inc. | 11.19M |
| MiMedx Group, Inc. | 74.00M |
| ABVC BioPharma, Inc. | -2.986M |
| Enovis Corp. | 217.29M |
| Edwards Lifesciences Corp. | 1.595B |